Diamonds & Dogs
JAMIE CARR: A bitter pill to swallow
Pharma companies caught between their obligation to shareholders and the moral duty to provide medicines at an affordable price
PSG Konsult stepping out of the shadowsSibling rivalry can be a powerful force, and it’s fair to say that it hasn’t been kind to PSG Konsult over the years. While Capitec and Curro have always been prom kings, dating all the cheerleaders and throwing the last-minute touchdown to lead the football team to victory, the third member of the PSG stable has been pedestrian, playing a solid role for the mathletes, but never threatening to approach the status of high school royalty. While it may have suffered in comparison with the stellar performance of its stablemates, PSG Konsult has quietly been ticking on and has produced an impressive set of results. The stand-out performance was from PSG Insure, which notched up recurring headline earnings growth of 70% in a particularly tricky industry environment. The business is in an early growth phase, and is chowing market share in its areas of focus as it benefits from economies of scale. PSG Asset Management also scored heavily, with recurrin...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.